Mutations in superoxide dismutase 1 (SOD1) cause familial ALS. Mutant SOD1 preferentially associates with the cytoplasmic face of mitochondria from spinal cords of rats and mice expressing SOD1 mutations. Two-dimensional gels and multidimensional liquid chromatography, in combination with tandem mass spectrometry, revealed 33 proteins that were increased and 21 proteins that were decreased in SOD1
Mutations in superoxide dismutase 1 (SOD1) cause familial ALS. Mutant SOD1 preferentially associates with the cytoplasmic face of mitochondria from spinal cords of rats and mice expressing SOD1 mutations. Two-dimensional gels and multidimensional liquid chromatography, in combination with tandem mass spectrometry, revealed 33 proteins that were increased and 21 proteins that were decreased in SOD1
G93A rat spinal cord mitochondria compared with SOD1
WT spinal cord mitochondria. Analysis of this group of proteins revealed a higher-than-expected proportion involved in complex I and protein import pathways. Direct import assays revealed a 30% decrease in protein import only in spinal cord mitochondria, despite an increase in the mitochondrial import components TOM20, TOM22, and TOM40. Recombinant SOD1 G93A or SOD1 G85R , but not SOD1
WT or a Parkinson's disease-causing, misfolded α-synuclein E46K mutant, decreased protein import by >50% in nontransgenic mitochondria from spinal cord, but not from liver. Thus, altered mitochondrial protein content accompanied by selective decreases in protein import into spinal cord mitochondria comprises part of the mitochondrial damage arising from mutant SOD1.
motor neuron disease | proteomic | neurodegenerative disease | amyotrophic A myotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disorder caused by loss of the motor neurons within the spinal cord and dysfunction of the motor pathways in the cortex (1, 2) . Most cases of ALS (90%) are sporadic. Of the 10% of cases that are inherited, about one-fifth are caused by mutation within the superoxide dismutase 1 (SOD1) gene. Rodents expressing mutant SOD1 develop an ALS-like disease (1, 2) . A consensus has emerged that disease arises from acquisition by the mutant proteins of one or more toxic properties, rather than from loss of dismutase activity (3, 4) . At least eight prominent mutant-derived toxicities have been proposed, including mitochondrial dysfunction, excitotoxicity, endoplasmic reticulum stress, toxic extracellular SOD1, superoxide production from microglia or astrocytes, and disruption of the blood-brain barrier (5) . Furthermore, pathogenesis is noncell autonomous with disease progression driven by mutant synthesis in astrocytes (6) (7) (8) and microglia (3, 9) .
Dysfunction of mitochondria can clearly cause specific damage to neurons or muscle because deletion/mutation in mitochondrial genes causes specific nerve and muscle diseases (10) . Accompanying mutant SOD1-mediated disease in some mice is evidence for altered mitochondrial calcium-buffering capacity (11) and changes in the activity of complexes of the electron transport chain (12) . Deletion of the mitochondrial BCL-2-related proteins BAX and BAK delays disease onset in SOD1 G93A mice (13) , perhaps by modulating effects of SOD1 conformational changes to BCL-2 (14) . Apparent damage to mitochondria has been reported in autopsy material from ALS patients (15, 16) .
Although SOD1 is a primarily cytosolic enzyme, wild-type SOD1 is also found in the intermembrane space of mitochondria in liver (17) and in yeast (18, 19) . However, in the normal nervous system very little SOD1 is found in or on mitochondria (20, 21) , but mutant SOD1 has been found associated presymptomatically with the cytoplasmic face of mitochondria from spinal cord in all rodent models of SOD1 mutant-mediated disease (20, 21) . A criticism that apparent association of dismutase inactive mutants with mitochondria might reflect cosedimentation of protein aggregates rather than bona fide mitochondrial association (22) has been refuted by demonstrating that mutant SOD1 floats with mitochondria rather than sedimenting as much more dense protein-only aggregates would under such conditions (21) . Indeed, a portion of misfolded mutant SOD1 directly binds to the cytoplasmic facing surface of the major voltage-dependent anion channel (VDAC1), a general diffusion pore for anions and cations that is located on the outer mitochondrial membrane. Mutant SOD1 binding reduces conductance by purified VDAC1 reconstituted in a lipid bilayer, and spinal cord mitochondria have reduced ADP uptake (23) .
Three prior efforts have reported use of proteomic tools to investigate how mutant SOD1 affects mitochondrial protein composition within whole-spinal-cord extracts of dismutase-active (24) or dismutase-inactive (25) SOD1 mutant mouse models or, more selectively, within mitochondria of a cell line retaining some motor neuron-like properties and expressing one dismutase-active, ALSlinked SOD1 mutant (26) . We extended these approaches to determine whether mutant SOD1 affects protein content of spinal cord mitochondria before disease initiation in rodent models that develop ALS-like disease. Using a combination of mass spectrometry and 2D gels, we now report 21 proteins to be decreased approximately twofold, with another 33 that are increased by a comparable amount or more in mitochondria isolated from spinal cords of mutant SOD1 animals, accompanied by diminished protein import activity. By using purified components, inhibition of mitochondrial protein import is demonstrated to be a direct result of mutant but not wild-type SOD1.
Results

Altered Spinal Cord Mitochondrial Protein Content in SOD1 Mutant
Rats. To identify possible differences in protein composition between mitochondria isolated from spinal cords of age-matched SOD1
WT and SOD1 G93A mutant rats, we used 2D gel electrophoresis as well as liquid chromatography followed by tandem mass spectrometry [multidimensional protein identification tech-nology (MudPIT)] (27) . Initially, a presymptomatic age (11 wk) was chosen because it was known to correspond to a time of very active denervation of lower motor neurons (28) . Although a change in staining on 2D gels may reflect altered abundance, size, or isoelectric point, the overall patterns of major proteins (visible in Coomassie (Fig. 1) or silver (Fig. S1 ) staining were highly similar. Twelve spots ( Fig. 1 B and C compared with Fig. 1 E and F and Fig. S1 B and C compared with Fig. S1 E and F) were clearly different between the two samples, with five (spots 1, 6, 7, 8, and 9) increased in SOD1 G93A mitochondria and seven (spots 2-5 and 10-12) decreased. Each was excised, digested with trypsin, and identified via tandem mass spectrometry (Table S1 ). Three spots contained more than one protein, resulting in a total of 15 proteins identified.
Using MudPIT mass spectrometry, protein differences were also identified from three independent preparations of mitochondria from 11-wk-old SOD1
WT and age-matched presymptomatic SOD1
G93A rat spinal cords, using normalized spectral counts as an indication of the relative amount of any given protein (29, 30) . We identified 299 mitochondrial proteins present in all of the mitochondrial samples. Most proteins (259) were unchanged in apparent abundance. However, 12 proteins were decreased by >0.6-fold and 28 proteins were increased by >1.8-fold (Table 1  and Table S2 ).
Hsp10, a cofactor for mitochondrial Hsp60 (31) and known to work as a stoichiometric partner chaperone for intramitochondrial protein folding, was predicted to be increased by mass spectrometry of SOD1
G93A mitochondria ( Table 1 ). Immunoblotting of whole-spinal-cord mitochondrial extract from rat SOD1 G93A confirmed induction (1.4-fold, P < 0.05) of Hsp10, but not of Hsp60, in SOD1 G93A mitochondria versus SOD1 WT mitochondria. Similar immunoblotting of mitochondria from human spinal cords of patients with SOD1 A4V or SOD1 I113T mutations revealed even more substantial increases (4.5-and 2.5-fold, respectively), in Hsp10 (Fig. 2) .
Decreased VDAC and cytochrome c oxidase subunits and increased adenylate kinase 2 seen here mirrored changes in wholespinal-cord extracts from a mutant SOD1 mouse (24) . Decreased VDAC, aconitase, isocitrate dehydrogenase (IDH3), and ATP synthase subunits and increased NDUFB8, a component of the electron transport complex I (see below), were found, similar to changes seen in mitochondria from an ALS-linked SOD1 mutant expressing a motor neuron-like cell line (26). 4-Aminobutyrate aminotransferase was increased and IDH3 was decreased in SOD1 G93A mitochondria, as assessed here by both 2D gels and mass spectrometry.
Only 26 mitochondrial proteins showed greater than twofold changes increased in SOD1
G93A spinal cord mitochondria relative to mitochondria from age-matched SOD1
WT rats expressing wildtype human SOD1 at comparable levels. Three of these are involved in protein import into mitochondria (TOM40, TOM20, and TOM22).
Decreased Complex I Activity in Mitochondria from SOD1 G93A Rats.
Six (NDUFS1, ND5, NDUFB8, NDUFC2, NDUFA5, NDUFB9) of the 26 down-regulated proteins in mitochondria from mutant spinal cord are components of the 42-subunit complex I, also known as NADH dehydrogenase. Complex I is located on the inner membrane of mitochondria, catalyzes the shuttling of electrons from NADH to coenzyme Q, and helps to build the proton gradient required for ATP generation. Immunoprecipitation of mitochondrial extracts with a monoclonal antibody raised against complex I, which had been crosslinked to protein G agarose beads (32) , confirmed that at least six complex I polypeptides were changed in relative abundance: two were increased [(V1, S2) and (A10, ND5)] and four were decreased [S1, (A9, D1), S3, and (B10, V2; B7, A5, B4, B5, B6, S5, B16, 6, A7)] (some stained bands represent multiple polypeptides) (Fig. 3A) . Of those decreased in SOD1 G93A mitochondria, a polypeptide migrating at 75 kDa ( Fig.  3A ) most likely represents S1 (also known as NDUFS1) (32) (33) (34) , which was also seen to be decreased by mass spectrometry (Table  1 ) and 2D gels (Fig. 3B, arrows) . A prominent complex I polypeptide migrating at 35 kDa, most likely representing ND5 (32) (33) (34) , was increased in immunoprecipitates. ND5 is a mitochondrially encoded core subunit of complex I believed to be important for catalysis (33) . Mass spectrometry confirmed the identity of ND5 and its increased relative abundance (Table 1) . Protein changes were more prominent in the spinal cord than in the liver (Fig. 3A) .
Complex I activity, measured by first immunoprecipitating the enzyme complex and subsequently measuring the passage of electrons to the colorimetric electron acceptor dye NBT (34), was 50% higher in liver versus spinal mitochondrial samples (normalized to citrate synthase activity). Activity was decreased by 25% in SOD1
G93A spinal cord mitochondria from symptomatic animals relative to mitochondria from SOD1
WT animals (Fig. 3C) . Surprisingly, a comparable decrease (30%) was also seen in complex I immunoprecipitated from mitochondria purified from livers of the same animals.
Protein Import Is Slowed in SOD1 G93A Spinal Cord Mitochondria.
Immunoblotting of extracts from isolated spinal cord mitochondria was used to more directly test the apparent increases in proteins involved in mitochondrial protein import that were found by mass spectrometry. For TOM40, a twofold increase was readily apparent in comparing its accumulated level (relative to COX4; Fig. 4A , Bottom) in SOD1 WT and SOD1 G93A mitochondrial extracts. A similar increase in full-length TOM40 was seen in liver mitochondria from mutant animals. In addition, an immunoreactive polypeptide of increased mobility (corresponding to ∼37 kDa) was found in the liver, but not in spinal cord fractions; this polypeptide too was elevated in mutant mitochondria. mRNA encoding TOM20, TOM22, and TOM40 were not significantly different in liver or spinal cord between SOD1
WT versus SOD1 G93A rats (Fig. S2 ). Isolated mitochondria from human lumbar spinal cord from a SOD1 A4V patient and SOD1 I113T patient showed a similar increase in TOM40 compared with control (Fig. 4B) . Although parallel analyses for TOM20 and TOM22 rats, separated by 2D gel electrophoresis, and stained with Coomassie blue. Spots that were different between SOD1 WT and SOD1 G93A were excised, digested with trypsin, and analyzed by mass spectrometry. See Table S1 for protein determinations.
revealed only marginal increases for each in rat SOD1
G93A spinal cord, increases in both were clearly evident in human spinal cord mitochondria from both SOD1 mutant samples (Fig. 4 A and B) .
Because prior efforts had revealed a proportion of mutant SOD1 to be bound on the cytoplasmic face of mitochondria (21) and the changes documented above in TOM40, we tested whether protein import was altered in spinal mitochondria from SOD1 G93A or SOD1
WT rats. Ornithine transcarbamylase (OTC) was used as an initial mitochondrial import substrate. The 39-kDa initial translation product of OTC carries a well-characterized mitochondrial import sequence, which includes an amino terminal signal sequence that is cleaved following mitochondrial entry into the matrix (35) . Successful OTC import can thus be detected by the appearance of the mature 36-kDa OTC polypeptide. 35 S-labeled OTC was synthesized in vitro and incubated with purified mitochondria and untransported OTC degraded by the addition of proteinase K. Within 15 min of incubation, the majority of OTC was successfully imported into mitochondria from liver or spinal cord of SOD1
WT rats (Fig. 4C ). Parallel incubations with mitochondria from spinal cord of symptomatic SOD1
G93A rats revealed a trend toward decrease (by ∼15%) in import ability (from three independent preparations with triplicate measurements for each independent preparation).
To test import of a second substrate (whose ultimate destination is to a second compartment within mitochondria), we tested 35 S-labeled iron sulfur protein (ISP), whose import is mediated via a well-defined import sequence that targets ISP to the inner mitochondrial membrane (36) . Spinal cord mitochondria from SOD1 G93A animals showed a significant 30% decrement (P < 0.05, Fig. 4D ) in their import ability. In a similar comparison of import, liver mitochondria were unchanged for ISP import and only marginally decreased (∼10%) for OTC (Fig. 4 C and D) . Because depletion of the mitochondrial transmembrane potential is a well-accepted inhibitor of mitochondrial protein import (37), we measured the transmembrane potential of isolated mitochondria using flow cytometry with the potentiometric dye TMRM. Depolarization of the mitochondrial membrane was easily Mitochondrial proteins in SOD1 WT and SOD1 G93A spinal cord were identified by using solution mass spectrometry (MudPIT). Relative amount of proteins was calculated by spectral counts, and the ratios of SOD1G93A: SOD1WT were averaged from three independent results. detected after addition of CCCP or ADP, which, as expected, produced severe or partial depolarization, respectively (Fig. 5A ).
Membrane potential was not changed in SOD1
G93A symptomatic mitochondria compared with SOD1 WT (Fig. 5B ). Reduction in complex IV, the last enzyme of the electron transport chain that transfers electrons from cytochrome C to molecular oxygen and in the process pumps protons across the inner membrane, has been previously implicated by one prior study of mitochondria from SOD1 G93A mice (38) . Although inhibition of this complex could secondarily affect protein import, no significant differences were detected between SOD1
WT and SOD1 G93A complex IV activities, despite a trend toward lower activity (Fig. S3A) . Finally, although a deficit in protein import could also be secondary to overall ATP synthesis rates, ATP synthesis did not differ between symptomatic SOD1
WT and SOD1 G93A animals (Fig. S3B ).
Direct Inhibition of Mitochondrial Protein Import by Mutant SOD1. To test for direct effects of mutant SOD1 on protein import, we combined mitochondria from spinal cord or liver of healthy nontransgenic rats with recombinant SOD1 proteins and then performed mitochondrial import assays. SOD1 WT protein had no effect on protein import of either of these isolated mitochondria preparations. In contrast, both SOD1 G93A and SOD1 G85R markedly decreased protein import of OTC (>50%) and ISP (>80%) 35 S-labeled proteins (Fig. 6) into spinal cord-derived mitochondria, but not of those isolated from liver. As with the mitochondria from SOD1 G93A rats (Fig. 4) , the effect on ISP import was more WT and SOD1 G93A rats, a nondiseased control patient, or (B) symptomatic ALS patients with SOD1
A4V or SOD1 I113T mutations. Proteins were separated by SDS/PAGE followed by immunoblotting for TOM20, TOM22, and TOM40. (C and D) Isolated mitochondria from symptomatic SOD1
WT or SOD1 G93A rats were incubated at 30°C for 15 min with 35 S-labeled OTC or 35 S-labeled ISP. Proteins were separated by SDS/PAGE. The gel was dried and exposed for radioisotopic imaging. Graphs represent the percentage of import. Average ± SD, n = 4, *P < 0.05. Representative gels are shown. mutations. Proteins were separated by gel electrophoresis followed by immunoblotting for COX4, Hsp10, and Hsp60. Average ± SD, n = 4, *P < 0.05. Fig. 3 . SOD1 G93A causes changes in complex I protein composition and decreased complex I activity. (A) Mitochondria were isolated from symptomatic SOD1
WT and SOD1 G93A liver and spinal cord, and complex I was immunoprecipitated with an antibody that recognizes and immunoprecipitates the entire complex. Individual proteins were visualized by SDS/PAGE followed by silver staining. Labels for polypeptides that increased or decreased in the SOD1 G93A mitochondrial samples are green or red, respectively. Individual proteins are labeled here on the basis of the previous silver-staining analyses of isolated complex I. (B) Mitochondrial proteins from SOD1
WT and SOD1
G93A
spinal cord were separated by 2D gels. The spot visually decreased in the SOD1 G93A sample (indicated by the arrow) was identified by mass spectrometry as S1 (also known as NDUFS1). (C) Complex I was immunoprecipitated from SOD1
WT and SOD1 G93A mitochondria, and the activity was determined and normalized to citrate synthase activity. Average ± SD, n = 4, *P < 0.05.
pronounced. None of the recombinant SOD1 proteins affected transmembrane potential (Fig. S4) . In addition, the absence of the effect of mutant SOD1 on protein import into liver mitochondria eliminated the possibility that the import deficit observed in spinal cord mitochondria derived from a mutant SOD1-mediated interference with the 35 S-labeled import substrates or other components of the assay. Mutations in α-synuclein cause Parkinson's disease and produce an encoded protein that misfolds (39, 40) and is linked to mitochondrial dysfunction (41) . Unlike mutant SOD1, neither purified mutant (E46K) nor wild-type α-synuclein affected protein import into spinal cord mitochondria, even when added to 20 times higher levels than those at which import was impaired by SOD1 mutants (Fig. 6C) .
Direct-binding targets of mutant SOD1 on the mitochondrial cytoplasmic face include VDAC1, which coimmunoprecipitates with mutant SOD1 whose binding to VDAC1 inhibits its conductance of adenine nucleotides (23) . We determined that other direct-binding targets on the mitochondrial outer surface do exist because mutant SOD1 still binds to spinal cord-derived mitochondria from VDAC1 null mice (Fig. S5) . Using immunoprecipitation for SOD1, we tested for direct binding of mutant SOD1 to the mitochondrial import components TOM20 and TOM40. Repeated attempts failed to generate evidence for an interaction, although antibody-binding sites could be occluded in any putative complex and transient interactions (as would be anticipated if mutant SOD1 were recognized as an import substrate) would not be expected to be detected by this kind of approach.
Discussion
Comparison of mitochondria from spinal cords of SOD1 WT versus SOD1
G93A rats revealed a handful of proteins whose abundance was substantially altered, accompanied by decreased protein import into spinal cord mitochondria from symptomatic SOD1 G93A animals. Elevation of the mitochondrial chaperone Hsp10 seen initially in mitochondria from SOD1 mutant rats was even more prominently found in spinal mitochondria from human patients with either of two SOD1 mutations (Fig. 2) . This is strongly indicative of the presence of an intramitochondrial stress that induces substantial elevation in this mitochondrial chaperone. Increased Hsp10, but not Hsp60, seen here in human mitochondria from SOD1 patients, is reminiscent of a similar divergence reported in subtypes of normal bone marrow cells (42) and in prostate cancer (43) . In all, these findings raise the possibility of another function for Hsp10 within mitochondria in addition to its role as an obligate cofactor for Hsp60.
Complex I proteins were also affected, accompanied by diminished complex I activity in SOD1 G93A mitochondria, whereas complex IV activity, the mitochondrial membrane potential, and ATP synthesis rates were unaffected. Along with other reports of diminished respiratory chain activities in SOD1 mice (44) , our evidence establishes deficits in complex I in liver mitochondria as well as in spinal cord mitochondria. Chronic inhibition of complex I is known to cause an increase in reactive oxygen species (45) , which may, in turn, further damage mitochondria.
Overall, these data (i) demonstrate that mitochondria are indeed a target of mutant SOD1 toxicity and (ii) identify specific mitochondrial pathways that are damaged, including reduced protein import, induction of protein-folding chaperone capacity, and decreased complex I activity. Recognizing that there may be a bias toward recovery of healthy mitochondria in biochemical purifications (because more highly damaged mitochondria may be rapidly eliminated in vivo and/or preferentially lost in the differential centrifugation steps used for mitochondrial isolation), it is likely that these changes represent at least some of the initial changes in mitochondrial composition from mutant SOD1. A plausible view is that vulnerable spinal cord cells have a lower intrinsic threshold for accumulation of mitochondrial defects secondary to damage to direct targets of mutant SOD1, including chronic, partial inhibition of complex I. This would be consistent with previously documented differences in mitochondria derived from brain and other tissues following inhibition of respiratory complexes (46) . Selective vulnerability may be derived from the known differences in protein composition in mitochondria from different tissues (30, 47) , the cellular environment of various tissues, or other unknown factors.
Protein import represents a critical pathway for mitochondria because, among the ∼1,400 estimated proteins in mitochondria, a mere 13 are encoded by mitochondrial DNA (47) (48) (49) . The other ∼1,387 proteins are delivered to mitochondria through the import pathways that we have demonstrated to be altered by SOD1 mutants, including changes in TOM40, TOM20, and TOM22. The increase in TOM20, TOM22, and TOM40 that we have found at the protein level occurred in mitochondria that were deficient in protein import. From this, we propose that the increased level of TOM components may reflect a response to a perceived deficit, although this response does not appear to be at the mRNA level because differences in TOM20, TOM22, and TOM40 mRNA were not found (Fig. S2) . (Although increases in TOM proteins could reflect altered stoichiometry of import proteins that may itself lead to decreased import, the finding that liver mitochondria show increased TOM proteins, yet no deficit in import, argues against this proposal.)
Our evidence that mitochondria from SOD1 G93A rats do not import mitochondrial proteins as well as SOD1
WT rat mitochondria extends to ALS previous findings that deficits in mitochondrial protein import are linked to neurodegenerative diseases. Included here are mutations in TIM8a, a translocase of the mitochondrial inner membrane, which are causative for deafness and dystonia in Mohr-Tranebjaerg syndrome (50) . Furthermore, single nucleotide polymorphisms in the TOM40 gene have been associated with an increased risk for late-onset Alzheimer's disease (51, 52) , and one previous study has suggested that amyloid-β associates directly with TOM40 (53) . Thus, our data add to a growing body of evidence that deficits in mitochondrial protein import pathways may contribute to neurodegenerative diseases. A key next test to establish the importance of reduced mitochondrial G85R (A and B) or with 7.5 μM α-synuclein WT or α-synuclein E46K (C) proteins for 15 min at 30°C. Then 35 S-labeled OTC (A) or 35 S-labeled ISP (B and C) was added for 15 min at 30°C to the mitochondria to assess protein import. Proteins were separated by SDS/PAGE. The gel was dried and exposed for radioisotopic imaging. Graphs represent the percentage of import. Average ± SD, n = 3, *P < 0.05. Representative gels are shown. import in ALS pathogenesis will be to use gene-targeted mice to further alter import activity and assess how this affects disease.
Materials and Methods
Fresh mitochondria were isolated from rat liver and spinal cord and kept on ice in cMRM (250 mM sucrose, 10 mM Hepes, pH 7.4, 0.8 mM ADP, 2 mM ATP, and 5 mM sodium succinate). Mitochondria (70 μg) were incubated with 3 μL of reticulocyte lysate containing 35 S-labeled proteins for 15 min at 30°C to perform the import reaction. After the incubation, mitochondria were reisolated by centrifugation at 10,000 × g for 5 min and subjected to SDS/PAGE. 35 S-labeled proteins were generated using a TNT kit (Promega). ISP and OTC plasmids were expressed in pGEM-3Z. Imported bands were quantified with a phosphorimager (Fujifilm FLA-7000). The recombinant proteins SOD1 WT , SOD1 G93A , and SOD1 G85R were generated in SF21 cells as previously described (23) . α-Synuclein [WT (S7820) and E46K (S4447)] was purchased from Sigma. Additional materials and methods are discussed in SI Materials and Methods.
